Trial Profile
A Randomised Controlled Trial of Selective Estrogen Receptor Modulators (SERMs) - A Potential Treatment for Psychotic Symptoms of Schizophrenia in Men?
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Nov 2023
Price :
$35
*
At a glance
- Drugs Raloxifene (Primary) ; Antipsychotics
- Indications Psychotic disorders; Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- 26 Nov 2023 Status changed from recruiting to completed.
- 06 Jan 2020 Planned End Date changed from 1 Dec 2018 to 1 Dec 2020.
- 06 Jan 2020 Planned primary completion date changed from 1 Dec 2018 to 1 Dec 2020.